Simarouba glauca, commonly known as the paradise tree, is a tropical medicinal plant rich in bioactive compounds, including quassinoids, triterpenes, flavonoids, and alkaloids, which exhibit notable anticancer, antimalarial, and anti-inflammatory activities. This mini-review critically examines literature from 2010-present to evaluate the chemical composition, pharmacological potential, and sustainable preparation strategies of these metabolites.

A particular focus is placed on catalyst-free green synthetic approaches, including solvent-minimized extractions, mechanochemical grinding, microwave-assisted isolations, and photochemical or multicomponent transformations. These methods allow the derivatization or isolation of natural products without metal catalysts or harsh reagents, minimizing environmental impact and avoiding residual contamination—key factors in developing clinically viable pharmaceuticals.

In addition, drug-delivery challenges such as poor solubility and limited bioavailability are addressed through literature-reported nano-formulations, liposomal carriers, and polymeric micelles that enhance stability and pharmacokinetic properties. Integrating green synthetic strategies with medicinal-chemistry perspectives highlights the potential of S. glauca metabolites as small-molecule drug candidates and illustrates a pathway toward environmentally responsible pharmaceutical development.

This literature-based perspective demonstrates how combining natural-product chemistry, catalyst-free sustainable methodologies, and modern pharmaceutics can advance drug discovery while reducing chemical waste. The review underscores key research gaps and proposes future directions for translating the bioactivity of Simarouba glauca into safe and sustainable therapeutic applications.